Triglyceride glucose index and heart attack treatment outcomes
Part of Heart & circulation clinical trials.
This study looks at whether a simple blood test (triglyceride glucose index) can help predict how well blocked heart arteries are opened after a heart attack treated with emergency angioplasty. It may help doctors better understand recovery and future risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You are having a type of heart attack called STEMI and are scheduled for emergency angioplasty (primary PCI).
- You have not had a previous heart artery bypass surgery or angioplasty with stents.
- You do not have a serious illness with less than 1 year life expectancy (like advanced liver or kidney disease on dialysis, or active cancer).
- You have not suffered a cardiac arrest that left you unconscious.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
This study examines whether a simple blood test measuring blood sugar and fat levels (the triglyceride-glucose index) can predict future heart problems in people who have had a heart attack without blocked arteries. The goal is to find better ways to monitor and treat these patients.
This trial studies whether a simple blood test called the triglyceride glucose index can help doctors understand heart artery disease in younger patients who do not have diabetes. It may lead to better ways to assess heart risk and guide treatment.
This study looks at how a simple blood test measure (the triglyceride glucose index) relates to the severity of blockages in heart arteries. It may help doctors understand risk better, especially for people undergoing a heart catheterization.
This trial is looking at how a simple blood test (triglyceride-glucose index) relates to complete blockages in heart arteries. It may help find people at higher risk without extra procedures.
Hear when a new STEMI - ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.